Development and external validation of a risk prediction tool for recurrent wheeze attacks in preschool children in England.

IF 4.4 3区 医学 Q1 RESPIRATORY SYSTEM
ERJ Open Research Pub Date : 2026-10-19 eCollection Date: 2026-09-01 DOI:10.1183/23120541.00337-2026
Jonathan Broomfield, Erol A Gaillard, Jennifer K Quint, Hilary Pinnock, Clare L Gillies, Mohammad A Al Sallakh, Gwyneth A Davies, David K H Lo
{"title":"Development and external validation of a risk prediction tool for recurrent wheeze attacks in preschool children in England.","authors":"Jonathan Broomfield, Erol A Gaillard, Jennifer K Quint, Hilary Pinnock, Clare L Gillies, Mohammad A Al Sallakh, Gwyneth A Davies, David K H Lo","doi":"10.1183/23120541.00337-2026","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Almost half of all children experience wheeze before their sixth birthday, with a subset experiencing recurrent attacks that increase healthcare burden. Early identification of children at high risk could enable timely interventions, but diagnostic tools are limited. The aim of the present study was to develop and validate a prognostic model predicting the risk of recurrent wheeze attacks (primary outcome) and hospitalisations (secondary outcome) within 12 months of an initial preschool acute wheeze presentation.</p><p><strong>Methods: </strong>We developed a multivariable logistic regression model using primary care data from 42 820 children in England aged up to 5 years with acute wheeze episodes recorded in the Clinical Practice Research Datalink. Predictors included demographics, clinical history and treatment patterns. The model was validated internally <i>via</i> bootstrapping and externally using the Secure Anonymised Information Linkage Databank in Wales (9703 children). Model performance was assessed using calibration and discrimination metrics.</p><p><strong>Results: </strong>In the CPRD development cohort, 39.6% experienced a subsequent wheeze attack and 17.4% were hospitalised. Key predictors were the healthcare setting of initial acute wheeze, prior wheeze history and reliever prescriptions; inhaled corticosteroid prescriptions reduced risk. The model demonstrated excellent calibration across internal bootstrap validation and two external validation cohorts (calibration slope=1.00, 0.94 and 0.86, respectively, calibration-in-the-large=0.00, 0.035 and -0.143) and moderate discrimination (C-statistic=0.634, 0.625 and 0.638 for wheeze).</p><p><strong>Conclusions: </strong>Using routinely collected data, the prognostic model shows strong calibration and moderate discrimination for predicting recurrent wheeze in preschool children. Implementation as a web tool could support early risk stratification and guide preventative management.</p>","PeriodicalId":11739,"journal":{"name":"ERJ Open Research","volume":"12 5","pages":""},"PeriodicalIF":4.4000,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13678849/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ERJ Open Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1183/23120541.00337-2026","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Almost half of all children experience wheeze before their sixth birthday, with a subset experiencing recurrent attacks that increase healthcare burden. Early identification of children at high risk could enable timely interventions, but diagnostic tools are limited. The aim of the present study was to develop and validate a prognostic model predicting the risk of recurrent wheeze attacks (primary outcome) and hospitalisations (secondary outcome) within 12 months of an initial preschool acute wheeze presentation.

Methods: We developed a multivariable logistic regression model using primary care data from 42 820 children in England aged up to 5 years with acute wheeze episodes recorded in the Clinical Practice Research Datalink. Predictors included demographics, clinical history and treatment patterns. The model was validated internally via bootstrapping and externally using the Secure Anonymised Information Linkage Databank in Wales (9703 children). Model performance was assessed using calibration and discrimination metrics.

Results: In the CPRD development cohort, 39.6% experienced a subsequent wheeze attack and 17.4% were hospitalised. Key predictors were the healthcare setting of initial acute wheeze, prior wheeze history and reliever prescriptions; inhaled corticosteroid prescriptions reduced risk. The model demonstrated excellent calibration across internal bootstrap validation and two external validation cohorts (calibration slope=1.00, 0.94 and 0.86, respectively, calibration-in-the-large=0.00, 0.035 and -0.143) and moderate discrimination (C-statistic=0.634, 0.625 and 0.638 for wheeze).

Conclusions: Using routinely collected data, the prognostic model shows strong calibration and moderate discrimination for predicting recurrent wheeze in preschool children. Implementation as a web tool could support early risk stratification and guide preventative management.

英国学龄前儿童复发性喘息发作风险预测工具的开发和外部验证。
简介:几乎一半的儿童在6岁生日之前经历喘息,其中一部分经历反复发作,增加了医疗负担。早期发现高危儿童可以及时采取干预措施,但诊断工具有限。本研究的目的是建立和验证一个预测模型,预测学龄前急性喘息首次出现后12个月内复发性喘息发作(主要结果)和住院(次要结果)的风险。方法:我们建立了一个多变量logistic回归模型,使用临床实践研究数据链中记录的42,820名英国5岁以下急性喘息发作儿童的初级保健数据。预测因素包括人口统计、临床病史和治疗模式。该模型通过内部引导和外部使用威尔士的安全匿名信息链接数据库(9703名儿童)进行验证。使用校准和判别指标评估模型性能。结果:在CPRD发展队列中,39.6%经历了随后的喘息发作,17.4%住院。关键预测因子为初始急性喘息的医疗环境、既往喘息史和缓解处方;吸入皮质类固醇处方降低了风险。该模型在内部bootstrap验证和两个外部验证队列(校准斜率分别为1.00、0.94和0.86,校准-in- large=0.00、0.035和-0.143)和中度判别(喘息的C-statistic=0.634、0.625和0.638)中具有良好的校准性。结论:使用常规收集的数据,该预测模型在预测学龄前儿童复发性喘息方面具有很强的校准性和适度的辨别性。作为网络工具的实施可以支持早期风险分层并指导预防性管理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ERJ Open Research
ERJ Open Research Medicine-Pulmonary and Respiratory Medicine
CiteScore
6.20
自引率
4.30%
发文量
273
审稿时长
8 weeks
期刊介绍: ERJ Open Research is a fully open access original research journal, published online by the European Respiratory Society. The journal aims to publish high-quality work in all fields of respiratory science and medicine, covering basic science, clinical translational science and clinical medicine. The journal was created to help fulfil the ERS objective to disseminate scientific and educational material to its members and to the medical community, but also to provide researchers with an affordable open access specialty journal in which to publish their work.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书